{
"@context": "https://schema.org",
"@type": "Article",
"headline": "FDA Simplifies and Clarifies Expanded Access Program",
"url": "https://www.lexblog.com/2017/10/09/fda-simplifies-and-clarifies-expanded-access-program/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-VMTXF86H",
"url": "https://www.lexblog.com/lib/VMTXF86H/"
},
"datePublished": "2017-10-09T17:28:40-04:00",
"dateModified": "2018-07-30T09:06:46-04:00",
"author": {
"@type": "Person",
"name": "HL Pharmaceutical & Biotechnology Team, Robert Church, Heidi Gertner, Bert Lao"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Hogan Lovells"
},
"organizationScope": "at-publication",
"isPartOf": "Focus on Regulation",
"about": "Food, Drug & Agriculture ยท Other",
"sourceUrl": "http://www.hlregulation.com/?p=10107",
"sourceStability": "may-move"
}